Abbott Introduces the Alinity hq Hematology Analyzer, the Newest Addition to the Alinity Family of Harmonized Systems

Hematology June 15, 2017 at 11:28 AM 0 comments

The Alinity hq next generation system is designed to streamline workflow and transform operational performance to help laboratories and hospital systems achieve measurably better healthcare performance. Maidenhead, UK, 15 June, 2017 – Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe andRead More

Abbott Broadens Product Offering in Coagulation with Expanded Launch of the Sekisui CP3000 Fully Automated Coagulation System

Hematology June 15, 2017 at 11:23 AM 0 comments

Coagulation tests measure a person’s blood clotting ability, which can help clinicians assess risks of excessive bleeding or clotting. The CP3000 coagulation system can optimize laboratory workflow and expedite the time to produce accurate test results. The system’s compact design and high-throughput testing capabilities make it one of the most efficient coagulation systemsRead More

RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis

Gastroenterology June 14, 2017 at 4:03 PM 0 comments

The positive Phase III top-line results indicate that the study successfully met its primary endpoint and BEKINDA® 24 mg was shown to be effective, safe and well tolerated in patients with acute gastroenteritis and gastritis RedHill will host a conference call and webcast to discuss the top-line results from theRead More

Acarix Receives First Commercial Order for CADScor®System for Early Detection of Coronary Artery Disease from Danish Hospital

Cardiology June 13, 2017 at 2:59 PM 0 comments

Commercialization program on track. Malmö, Sweden, 13 June, 2017 – Acarix AB (publ) (“Acarix” or the “Company”) today announced that Herning Hospital has placed the first commercial order for the CADScor®System for non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD). Researchers at the hospital have extensively trialed CADScor®System andRead More

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

Cardiology, Diabetes June 13, 2017 at 2:52 PM 0 comments

Bagsværd, Denmark, 13 June, 2017 – Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza® (liraglutide) resulted in similar reductions in the risk of major cardiovascular events in people with type 2 diabetes at high CV risk, regardless of whether orRead More

PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

Oncology June 13, 2017 at 2:45 PM 0 comments

Madrid, Spain, 13 June, 2017 – PharmaMar (MCE: PHM) has participated in the Annual Meeting of the American society of Clinical Oncology (ASCO) with new data with inhibitors of activated transcription, Yondelis® and lurbinectedin. The Company has presented various studies in different types of tumors, amongst which can be highlighted the resultsRead More

Abiraterone Acetate Plus Prednisone Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival

Oncology, Urology June 8, 2017 at 9:18 AM 0 comments

Beerse, Belgium, 3 June, 2017 – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga® (abiraterone acetate) plus prednisone, in combination with androgen deprivation therapy (ADT), compared to ADT plus placebo, demonstrated a significant improvement in overall survival (OS) and radiographic progression-free survivalRead More

Introducing EMJ Hepatology 5.1

Introducing EMJ Hepatology 5.1

Uncategorized June 8, 2017 at 8:49 AM 0 comments

United Kingdom, June 08, 2017: Welcome to the latest edition of our EMJ Hepatology eJournal! This issue is jam-packed with the latest hepatological updates, including cutting edge peer-reviewed articles, interesting abstracts from this year’s International Liver CongressTM (ILC) 2017, and thought-provoking features. We also share interviews with four members ofRead More

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

Oncology June 6, 2017 at 12:17 PM 0 comments

Median progression free survival (PFS) close to double the reported median PFS in other clinical studies. Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases today announces compelling single agent clinical dataRead More

F-Star Expands Its Relationship with Merck Through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology

Uncategorized June 5, 2017 at 12:27 PM 0 comments

New strategic collaboration to develop and commercialise five bispecific immuno-oncology antibodies, including F-star’s lead asset FS118 F-star to receive up to €115 million over the first two years Merck has option to acquire the programmes, with potential deal value of over €1 billion Cambridge, UK, June 04, 2017 – F-star,Read More